Sustained response to anakinra in ankylosing spondylitis.
Bennett
A N
AN
Tan
A L
AL
Coates
L C
LC
Emery
P
P
Marzo-Ortega
H
H
McGonagle
D
D
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000378:metabolism; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D011788:Quality of Life; D013167:Spondylitis, Ankylosing / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D002097:C-Reactive Protein